Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria

Alberto Ponzone, Marco Spada, Luca Roasio, Francesco Porta, Alessandro Mussa, Silvio Ferraris

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objectives: Early blood phenylalanine (Phe) elevation after birth enables screening for and anticipation of the diagnosis of phenylketonuria. The differential impact of factors involved in this phenomenon, however, has not been elucidated. To solve this question, phenotype, genotype, dietary Phe intake, timing of blood collection, and Phe metabolism were retrospectively analyzed in 21 phenylketonuria newborns and prospectively in 1. Patients and Methods: Patients were assigned to 1 of 4 classes of phenylalanine hydroxylase (PAH) deficiency (severe, moderate, mild, and benign) on the basis of their Phe tolerance. Phe ingested, tolerated, and released from endogenous catabolism was assessed. Results: From birth to screening test, the amount of Phe tolerated ranged from 704 to 1620 mg, according to the class of PAH deficiency. The amount of Phe ingested ranged only from 204 to 405 mg, whereas the endogenous Phe breakdown ranged from 812 to 1534 mg, resulting in a rate of Phe catabolism ranging from 262 to 341 mg/day, regardless of the class of PAH deficiency. Conclusions: The high rate of protein catabolism is the main determinant of neonatal hyperphenylalaninemia. It is sufficient to turn to positive the screening test in severe and moderate PAH deficiency. In mild and benign PAH deficiency, the outcome of screening procedures can be substantially altered by the concurrence of genetic and peristatic factors. These results imply that the value of blood Phe at the screening test is not fully predictive of the phenylketonuria phenotype, and strengthen concerns regarding the reliability of early screening procedures.

Original languageEnglish
Pages (from-to)561-569
Number of pages9
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume46
Issue number5
DOIs
Publication statusPublished - May 2008

Fingerprint

phenylketonuria
Phenylketonurias
protein metabolism
phenylalanine 4-monooxygenase
Phenylalanine
phenylalanine
nutrition
screening
Proteins
metabolism
blood
Parturition
Phenotype
phenotype
neonates
Genotype
Newborn Infant

Keywords

  • Neonatal screening
  • Phenylalanine tolerance
  • Phenylketonuria
  • Protein catabolism

ASJC Scopus subject areas

  • Gastroenterology
  • Pediatrics, Perinatology, and Child Health
  • Histology
  • Medicine (miscellaneous)
  • Food Science

Cite this

Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria. / Ponzone, Alberto; Spada, Marco; Roasio, Luca; Porta, Francesco; Mussa, Alessandro; Ferraris, Silvio.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 46, No. 5, 05.2008, p. 561-569.

Research output: Contribution to journalArticle

Ponzone, Alberto ; Spada, Marco ; Roasio, Luca ; Porta, Francesco ; Mussa, Alessandro ; Ferraris, Silvio. / Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria. In: Journal of Pediatric Gastroenterology and Nutrition. 2008 ; Vol. 46, No. 5. pp. 561-569.
@article{53e62771bcc84524a82f10a4b7b68ac3,
title = "Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria",
abstract = "Objectives: Early blood phenylalanine (Phe) elevation after birth enables screening for and anticipation of the diagnosis of phenylketonuria. The differential impact of factors involved in this phenomenon, however, has not been elucidated. To solve this question, phenotype, genotype, dietary Phe intake, timing of blood collection, and Phe metabolism were retrospectively analyzed in 21 phenylketonuria newborns and prospectively in 1. Patients and Methods: Patients were assigned to 1 of 4 classes of phenylalanine hydroxylase (PAH) deficiency (severe, moderate, mild, and benign) on the basis of their Phe tolerance. Phe ingested, tolerated, and released from endogenous catabolism was assessed. Results: From birth to screening test, the amount of Phe tolerated ranged from 704 to 1620 mg, according to the class of PAH deficiency. The amount of Phe ingested ranged only from 204 to 405 mg, whereas the endogenous Phe breakdown ranged from 812 to 1534 mg, resulting in a rate of Phe catabolism ranging from 262 to 341 mg/day, regardless of the class of PAH deficiency. Conclusions: The high rate of protein catabolism is the main determinant of neonatal hyperphenylalaninemia. It is sufficient to turn to positive the screening test in severe and moderate PAH deficiency. In mild and benign PAH deficiency, the outcome of screening procedures can be substantially altered by the concurrence of genetic and peristatic factors. These results imply that the value of blood Phe at the screening test is not fully predictive of the phenylketonuria phenotype, and strengthen concerns regarding the reliability of early screening procedures.",
keywords = "Neonatal screening, Phenylalanine tolerance, Phenylketonuria, Protein catabolism",
author = "Alberto Ponzone and Marco Spada and Luca Roasio and Francesco Porta and Alessandro Mussa and Silvio Ferraris",
year = "2008",
month = "5",
doi = "10.1097/MPG.0b013e31815eead6",
language = "English",
volume = "46",
pages = "561--569",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria

AU - Ponzone, Alberto

AU - Spada, Marco

AU - Roasio, Luca

AU - Porta, Francesco

AU - Mussa, Alessandro

AU - Ferraris, Silvio

PY - 2008/5

Y1 - 2008/5

N2 - Objectives: Early blood phenylalanine (Phe) elevation after birth enables screening for and anticipation of the diagnosis of phenylketonuria. The differential impact of factors involved in this phenomenon, however, has not been elucidated. To solve this question, phenotype, genotype, dietary Phe intake, timing of blood collection, and Phe metabolism were retrospectively analyzed in 21 phenylketonuria newborns and prospectively in 1. Patients and Methods: Patients were assigned to 1 of 4 classes of phenylalanine hydroxylase (PAH) deficiency (severe, moderate, mild, and benign) on the basis of their Phe tolerance. Phe ingested, tolerated, and released from endogenous catabolism was assessed. Results: From birth to screening test, the amount of Phe tolerated ranged from 704 to 1620 mg, according to the class of PAH deficiency. The amount of Phe ingested ranged only from 204 to 405 mg, whereas the endogenous Phe breakdown ranged from 812 to 1534 mg, resulting in a rate of Phe catabolism ranging from 262 to 341 mg/day, regardless of the class of PAH deficiency. Conclusions: The high rate of protein catabolism is the main determinant of neonatal hyperphenylalaninemia. It is sufficient to turn to positive the screening test in severe and moderate PAH deficiency. In mild and benign PAH deficiency, the outcome of screening procedures can be substantially altered by the concurrence of genetic and peristatic factors. These results imply that the value of blood Phe at the screening test is not fully predictive of the phenylketonuria phenotype, and strengthen concerns regarding the reliability of early screening procedures.

AB - Objectives: Early blood phenylalanine (Phe) elevation after birth enables screening for and anticipation of the diagnosis of phenylketonuria. The differential impact of factors involved in this phenomenon, however, has not been elucidated. To solve this question, phenotype, genotype, dietary Phe intake, timing of blood collection, and Phe metabolism were retrospectively analyzed in 21 phenylketonuria newborns and prospectively in 1. Patients and Methods: Patients were assigned to 1 of 4 classes of phenylalanine hydroxylase (PAH) deficiency (severe, moderate, mild, and benign) on the basis of their Phe tolerance. Phe ingested, tolerated, and released from endogenous catabolism was assessed. Results: From birth to screening test, the amount of Phe tolerated ranged from 704 to 1620 mg, according to the class of PAH deficiency. The amount of Phe ingested ranged only from 204 to 405 mg, whereas the endogenous Phe breakdown ranged from 812 to 1534 mg, resulting in a rate of Phe catabolism ranging from 262 to 341 mg/day, regardless of the class of PAH deficiency. Conclusions: The high rate of protein catabolism is the main determinant of neonatal hyperphenylalaninemia. It is sufficient to turn to positive the screening test in severe and moderate PAH deficiency. In mild and benign PAH deficiency, the outcome of screening procedures can be substantially altered by the concurrence of genetic and peristatic factors. These results imply that the value of blood Phe at the screening test is not fully predictive of the phenylketonuria phenotype, and strengthen concerns regarding the reliability of early screening procedures.

KW - Neonatal screening

KW - Phenylalanine tolerance

KW - Phenylketonuria

KW - Protein catabolism

UR - http://www.scopus.com/inward/record.url?scp=48249100160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249100160&partnerID=8YFLogxK

U2 - 10.1097/MPG.0b013e31815eead6

DO - 10.1097/MPG.0b013e31815eead6

M3 - Article

C2 - 18493213

AN - SCOPUS:48249100160

VL - 46

SP - 561

EP - 569

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 5

ER -